Global Anti-tuberculosis Medicine Supply, Demand and Key Producers, 2024-2030

Description

The global Anti-tuberculosis Medicine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Anti-tuberculosis Medicine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Anti-tuberculosis Medicine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-tuberculosis Medicine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Anti-tuberculosis Medicine total production and demand, 2019-2030, (Kiliton)
Global Anti-tuberculosis Medicine total production value, 2019-2030, (USD Million)
Global Anti-tuberculosis Medicine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Kiliton)
Global Anti-tuberculosis Medicine consumption by region & country, CAGR, 2019-2030 & (Kiliton)
U.S. VS China: Anti-tuberculosis Medicine domestic production, consumption, key domestic manufacturers and share
Global Anti-tuberculosis Medicine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Kiliton)
Global Anti-tuberculosis Medicine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Kiliton)
Global Anti-tuberculosis Medicine production by Application production, value, CAGR, 2019-2030, (USD Million) & (Kiliton).

This reports profiles key players in the global Anti-tuberculosis Medicine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca and Bayer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-tuberculosis Medicine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Kiliton) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Anti-tuberculosis Medicine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Anti-tuberculosis Medicine Market, Segmentation by Type
    Isoniazid
    Rifampin
    Ethambutol
    Pyrazinamide
    Otherr

Global Anti-tuberculosis Medicine Market, Segmentation by Application
    Hospitals and Clinics
    Government Agencies
    Non-Profit Organizations
    Others

Companies Profiled:
    Lupin
    Macleods Pharmaceuticals
    Otsuka Pharmaceutical
    Johnson & Johnson
    Pfizer
    Novartis
    Abbott
    AstraZeneca
    Bayer
    Eli Lilly
    GlaxoSmithKline
    Merck
    Sanofi
    Chongqing Huapont Pharm
    Shuangding Pharm
    Hongqi pharmaceutical

Key Questions Answered
1. How big is the global Anti-tuberculosis Medicine market?
2. What is the demand of the global Anti-tuberculosis Medicine market?
3. What is the year over year growth of the global Anti-tuberculosis Medicine market?
4. What is the production and production value of the global Anti-tuberculosis Medicine market?
5. Who are the key producers in the global Anti-tuberculosis Medicine market?

Table of Contents

1 Supply Summary
    1.1 Anti-tuberculosis Medicine Introduction
    1.2 World Anti-tuberculosis Medicine Supply & Forecast
        1.2.1 World Anti-tuberculosis Medicine Production Value (2019 & 2023 & 2030)
        1.2.2 World Anti-tuberculosis Medicine Production (2019-2030)
        1.2.3 World Anti-tuberculosis Medicine Pricing Trends (2019-2030)
    1.3 World Anti-tuberculosis Medicine Production by Region (Based on Production Site)
        1.3.1 World Anti-tuberculosis Medicine Production Value by Region (2019-2030)
        1.3.2 World Anti-tuberculosis Medicine Production by Region (2019-2030)
        1.3.3 World Anti-tuberculosis Medicine Average Price by Region (2019-2030)
        1.3.4 North America Anti-tuberculosis Medicine Production (2019-2030)
        1.3.5 Europe Anti-tuberculosis Medicine Production (2019-2030)
        1.3.6 China Anti-tuberculosis Medicine Production (2019-2030)
        1.3.7 Japan Anti-tuberculosis Medicine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Anti-tuberculosis Medicine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Anti-tuberculosis Medicine Major Market Trends

2 Demand Summary
    2.1 World Anti-tuberculosis Medicine Demand (2019-2030)
    2.2 World Anti-tuberculosis Medicine Consumption by Region
        2.2.1 World Anti-tuberculosis Medicine Consumption by Region (2019-2024)
        2.2.2 World Anti-tuberculosis Medicine Consumption Forecast by Region (2025-2030)
    2.3 United States Anti-tuberculosis Medicine Consumption (2019-2030)
    2.4 China Anti-tuberculosis Medicine Consumption (2019-2030)
    2.5 Europe Anti-tuberculosis Medicine Consumption (2019-2030)
    2.6 Japan Anti-tuberculosis Medicine Consumption (2019-2030)
    2.7 South Korea Anti-tuberculosis Medicine Consumption (2019-2030)
    2.8 ASEAN Anti-tuberculosis Medicine Consumption (2019-2030)
    2.9 India Anti-tuberculosis Medicine Consumption (2019-2030)

3 World Anti-tuberculosis Medicine Manufacturers Competitive Analysis
    3.1 World Anti-tuberculosis Medicine Production Value by Manufacturer (2019-2024)
    3.2 World Anti-tuberculosis Medicine Production by Manufacturer (2019-2024)
    3.3 World Anti-tuberculosis Medicine Average Price by Manufacturer (2019-2024)
    3.4 Anti-tuberculosis Medicine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Anti-tuberculosis Medicine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Anti-tuberculosis Medicine in 2023
        3.5.3 Global Concentration Ratios (CR8) for Anti-tuberculosis Medicine in 2023
    3.6 Anti-tuberculosis Medicine Market: Overall Company Footprint Analysis
        3.6.1 Anti-tuberculosis Medicine Market: Region Footprint
        3.6.2 Anti-tuberculosis Medicine Market: Company Product Type Footprint
        3.6.3 Anti-tuberculosis Medicine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Anti-tuberculosis Medicine Production Value Comparison
        4.1.1 United States VS China: Anti-tuberculosis Medicine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Anti-tuberculosis Medicine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Anti-tuberculosis Medicine Production Comparison
        4.2.1 United States VS China: Anti-tuberculosis Medicine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Anti-tuberculosis Medicine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Anti-tuberculosis Medicine Consumption Comparison
        4.3.1 United States VS China: Anti-tuberculosis Medicine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Anti-tuberculosis Medicine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Anti-tuberculosis Medicine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Anti-tuberculosis Medicine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Anti-tuberculosis Medicine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Anti-tuberculosis Medicine Production (2019-2024)
    4.5 China Based Anti-tuberculosis Medicine Manufacturers and Market Share
        4.5.1 China Based Anti-tuberculosis Medicine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Anti-tuberculosis Medicine Production Value (2019-2024)
        4.5.3 China Based Manufacturers Anti-tuberculosis Medicine Production (2019-2024)
    4.6 Rest of World Based Anti-tuberculosis Medicine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Anti-tuberculosis Medicine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Anti-tuberculosis Medicine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Anti-tuberculosis Medicine Production (2019-2024)

5 Market Analysis by Type
    5.1 World Anti-tuberculosis Medicine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Isoniazid
        5.2.2 Rifampin
        5.2.3 Ethambutol
        5.2.4 Pyrazinamide
        5.2.5 Otherr
    5.3 Market Segment by Type
        5.3.1 World Anti-tuberculosis Medicine Production by Type (2019-2030)
        5.3.2 World Anti-tuberculosis Medicine Production Value by Type (2019-2030)
        5.3.3 World Anti-tuberculosis Medicine Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Anti-tuberculosis Medicine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospitals and Clinics
        6.2.2 Government Agencies
        6.2.3 Non-Profit Organizations
        6.2.4 Others
    6.3 Market Segment by Application
        6.3.1 World Anti-tuberculosis Medicine Production by Application (2019-2030)
        6.3.2 World Anti-tuberculosis Medicine Production Value by Application (2019-2030)
        6.3.3 World Anti-tuberculosis Medicine Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Lupin
        7.1.1 Lupin Details
        7.1.2 Lupin Major Business
        7.1.3 Lupin Anti-tuberculosis Medicine Product and Services
        7.1.4 Lupin Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Lupin Recent Developments/Updates
        7.1.6 Lupin Competitive Strengths & Weaknesses
    7.2 Macleods Pharmaceuticals
        7.2.1 Macleods Pharmaceuticals Details
        7.2.2 Macleods Pharmaceuticals Major Business
        7.2.3 Macleods Pharmaceuticals Anti-tuberculosis Medicine Product and Services
        7.2.4 Macleods Pharmaceuticals Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Macleods Pharmaceuticals Recent Developments/Updates
        7.2.6 Macleods Pharmaceuticals Competitive Strengths & Weaknesses
    7.3 Otsuka Pharmaceutical
        7.3.1 Otsuka Pharmaceutical Details
        7.3.2 Otsuka Pharmaceutical Major Business
        7.3.3 Otsuka Pharmaceutical Anti-tuberculosis Medicine Product and Services
        7.3.4 Otsuka Pharmaceutical Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Otsuka Pharmaceutical Recent Developments/Updates
        7.3.6 Otsuka Pharmaceutical Competitive Strengths & Weaknesses
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Details
        7.4.2 Johnson & Johnson Major Business
        7.4.3 Johnson & Johnson Anti-tuberculosis Medicine Product and Services
        7.4.4 Johnson & Johnson Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Johnson & Johnson Recent Developments/Updates
        7.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.5 Pfizer
        7.5.1 Pfizer Details
        7.5.2 Pfizer Major Business
        7.5.3 Pfizer Anti-tuberculosis Medicine Product and Services
        7.5.4 Pfizer Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Pfizer Recent Developments/Updates
        7.5.6 Pfizer Competitive Strengths & Weaknesses
    7.6 Novartis
        7.6.1 Novartis Details
        7.6.2 Novartis Major Business
        7.6.3 Novartis Anti-tuberculosis Medicine Product and Services
        7.6.4 Novartis Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Novartis Recent Developments/Updates
        7.6.6 Novartis Competitive Strengths & Weaknesses
    7.7 Abbott
        7.7.1 Abbott Details
        7.7.2 Abbott Major Business
        7.7.3 Abbott Anti-tuberculosis Medicine Product and Services
        7.7.4 Abbott Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Abbott Recent Developments/Updates
        7.7.6 Abbott Competitive Strengths & Weaknesses
    7.8 AstraZeneca
        7.8.1 AstraZeneca Details
        7.8.2 AstraZeneca Major Business
        7.8.3 AstraZeneca Anti-tuberculosis Medicine Product and Services
        7.8.4 AstraZeneca Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 AstraZeneca Recent Developments/Updates
        7.8.6 AstraZeneca Competitive Strengths & Weaknesses
    7.9 Bayer
        7.9.1 Bayer Details
        7.9.2 Bayer Major Business
        7.9.3 Bayer Anti-tuberculosis Medicine Product and Services
        7.9.4 Bayer Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Bayer Recent Developments/Updates
        7.9.6 Bayer Competitive Strengths & Weaknesses
    7.10 Eli Lilly
        7.10.1 Eli Lilly Details
        7.10.2 Eli Lilly Major Business
        7.10.3 Eli Lilly Anti-tuberculosis Medicine Product and Services
        7.10.4 Eli Lilly Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Eli Lilly Recent Developments/Updates
        7.10.6 Eli Lilly Competitive Strengths & Weaknesses
    7.11 GlaxoSmithKline
        7.11.1 GlaxoSmithKline Details
        7.11.2 GlaxoSmithKline Major Business
        7.11.3 GlaxoSmithKline Anti-tuberculosis Medicine Product and Services
        7.11.4 GlaxoSmithKline Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 GlaxoSmithKline Recent Developments/Updates
        7.11.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.12 Merck
        7.12.1 Merck Details
        7.12.2 Merck Major Business
        7.12.3 Merck Anti-tuberculosis Medicine Product and Services
        7.12.4 Merck Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Merck Recent Developments/Updates
        7.12.6 Merck Competitive Strengths & Weaknesses
    7.13 Sanofi
        7.13.1 Sanofi Details
        7.13.2 Sanofi Major Business
        7.13.3 Sanofi Anti-tuberculosis Medicine Product and Services
        7.13.4 Sanofi Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Sanofi Recent Developments/Updates
        7.13.6 Sanofi Competitive Strengths & Weaknesses
    7.14 Chongqing Huapont Pharm
        7.14.1 Chongqing Huapont Pharm Details
        7.14.2 Chongqing Huapont Pharm Major Business
        7.14.3 Chongqing Huapont Pharm Anti-tuberculosis Medicine Product and Services
        7.14.4 Chongqing Huapont Pharm Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Chongqing Huapont Pharm Recent Developments/Updates
        7.14.6 Chongqing Huapont Pharm Competitive Strengths & Weaknesses
    7.15 Shuangding Pharm
        7.15.1 Shuangding Pharm Details
        7.15.2 Shuangding Pharm Major Business
        7.15.3 Shuangding Pharm Anti-tuberculosis Medicine Product and Services
        7.15.4 Shuangding Pharm Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 Shuangding Pharm Recent Developments/Updates
        7.15.6 Shuangding Pharm Competitive Strengths & Weaknesses
    7.16 Hongqi pharmaceutical
        7.16.1 Hongqi pharmaceutical Details
        7.16.2 Hongqi pharmaceutical Major Business
        7.16.3 Hongqi pharmaceutical Anti-tuberculosis Medicine Product and Services
        7.16.4 Hongqi pharmaceutical Anti-tuberculosis Medicine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.16.5 Hongqi pharmaceutical Recent Developments/Updates
        7.16.6 Hongqi pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Anti-tuberculosis Medicine Industry Chain
    8.2 Anti-tuberculosis Medicine Upstream Analysis
        8.2.1 Anti-tuberculosis Medicine Core Raw Materials
        8.2.2 Main Manufacturers of Anti-tuberculosis Medicine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Anti-tuberculosis Medicine Production Mode
    8.6 Anti-tuberculosis Medicine Procurement Model
    8.7 Anti-tuberculosis Medicine Industry Sales Model and Sales Channels
        8.7.1 Anti-tuberculosis Medicine Sales Model
        8.7.2 Anti-tuberculosis Medicine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Anti-tuberculosis Medicine Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Anti-tuberculosis Medicine Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Anti-tuberculosis Medicine Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Anti-tuberculosis Medicine Production Value Market Share by Region (2019-2024)
    Table 5. World Anti-tuberculosis Medicine Production Value Market Share by Region (2025-2030)
    Table 6. World Anti-tuberculosis Medicine Production by Region (2019-2024) & (Kiliton)
    Table 7. World Anti-tuberculosis Medicine Production by Region (2025-2030) & (Kiliton)
    Table 8. World Anti-tuberculosis Medicine Production Market Share by Region (2019-2024)
    Table 9. World Anti-tuberculosis Medicine Production Market Share by Region (2025-2030)
    Table 10. World Anti-tuberculosis Medicine Average Price by Region (2019-2024) & (US$/Ton)
    Table 11. World Anti-tuberculosis Medicine Average Price by Region (2025-2030) & (US$/Ton)
    Table 12. Anti-tuberculosis Medicine Major Market Trends
    Table 13. World Anti-tuberculosis Medicine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (Kiliton)
    Table 14. World Anti-tuberculosis Medicine Consumption by Region (2019-2024) & (Kiliton)
    Table 15. World Anti-tuberculosis Medicine Consumption Forecast by Region (2025-2030) & (Kiliton)
    Table 16. World Anti-tuberculosis Medicine Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Anti-tuberculosis Medicine Producers in 2023
    Table 18. World Anti-tuberculosis Medicine Production by Manufacturer (2019-2024) & (Kiliton)
    Table 19. Production Market Share of Key Anti-tuberculosis Medicine Producers in 2023
    Table 20. World Anti-tuberculosis Medicine Average Price by Manufacturer (2019-2024) & (US$/Ton)
    Table 21. Global Anti-tuberculosis Medicine Company Evaluation Quadrant
    Table 22. World Anti-tuberculosis Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Anti-tuberculosis Medicine Production Site of Key Manufacturer
    Table 24. Anti-tuberculosis Medicine Market: Company Product Type Footprint
    Table 25. Anti-tuberculosis Medicine Market: Company Product Application Footprint
    Table 26. Anti-tuberculosis Medicine Competitive Factors
    Table 27. Anti-tuberculosis Medicine New Entrant and Capacity Expansion Plans
    Table 28. Anti-tuberculosis Medicine Mergers & Acquisitions Activity
    Table 29. United States VS China Anti-tuberculosis Medicine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Anti-tuberculosis Medicine Production Comparison, (2019 & 2023 & 2030) & (Kiliton)
    Table 31. United States VS China Anti-tuberculosis Medicine Consumption Comparison, (2019 & 2023 & 2030) & (Kiliton)
    Table 32. United States Based Anti-tuberculosis Medicine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Anti-tuberculosis Medicine Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Anti-tuberculosis Medicine Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Anti-tuberculosis Medicine Production (2019-2024) & (Kiliton)
    Table 36. United States Based Manufacturers Anti-tuberculosis Medicine Production Market Share (2019-2024)
    Table 37. China Based Anti-tuberculosis Medicine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Anti-tuberculosis Medicine Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Anti-tuberculosis Medicine Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Anti-tuberculosis Medicine Production (2019-2024) & (Kiliton)
    Table 41. China Based Manufacturers Anti-tuberculosis Medicine Production Market Share (2019-2024)
    Table 42. Rest of World Based Anti-tuberculosis Medicine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Anti-tuberculosis Medicine Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Anti-tuberculosis Medicine Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Anti-tuberculosis Medicine Production (2019-2024) & (Kiliton)
    Table 46. Rest of World Based Manufacturers Anti-tuberculosis Medicine Production Market Share (2019-2024)
    Table 47. World Anti-tuberculosis Medicine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Anti-tuberculosis Medicine Production by Type (2019-2024) & (Kiliton)
    Table 49. World Anti-tuberculosis Medicine Production by Type (2025-2030) & (Kiliton)
    Table 50. World Anti-tuberculosis Medicine Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Anti-tuberculosis Medicine Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Anti-tuberculosis Medicine Average Price by Type (2019-2024) & (US$/Ton)
    Table 53. World Anti-tuberculosis Medicine Average Price by Type (2025-2030) & (US$/Ton)
    Table 54. World Anti-tuberculosis Medicine Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Anti-tuberculosis Medicine Production by Application (2019-2024) & (Kiliton)
    Table 56. World Anti-tuberculosis Medicine Production by Application (2025-2030) & (Kiliton)
    Table 57. World Anti-tuberculosis Medicine Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Anti-tuberculosis Medicine Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Anti-tuberculosis Medicine Average Price by Application (2019-2024) & (US$/Ton)
    Table 60. World Anti-tuberculosis Medicine Average Price by Application (2025-2030) & (US$/Ton)
    Table 61. Lupin Basic Information, Manufacturing Base and Competitors
    Table 62. Lupin Major Business
    Table 63. Lupin Anti-tuberculosis Medicine Product and Services
    Table 64. Lupin Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Lupin Recent Developments/Updates
    Table 66. Lupin Competitive Strengths & Weaknesses
    Table 67. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 68. Macleods Pharmaceuticals Major Business
    Table 69. Macleods Pharmaceuticals Anti-tuberculosis Medicine Product and Services
    Table 70. Macleods Pharmaceuticals Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Macleods Pharmaceuticals Recent Developments/Updates
    Table 72. Macleods Pharmaceuticals Competitive Strengths & Weaknesses
    Table 73. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 74. Otsuka Pharmaceutical Major Business
    Table 75. Otsuka Pharmaceutical Anti-tuberculosis Medicine Product and Services
    Table 76. Otsuka Pharmaceutical Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Otsuka Pharmaceutical Recent Developments/Updates
    Table 78. Otsuka Pharmaceutical Competitive Strengths & Weaknesses
    Table 79. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 80. Johnson & Johnson Major Business
    Table 81. Johnson & Johnson Anti-tuberculosis Medicine Product and Services
    Table 82. Johnson & Johnson Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Johnson & Johnson Recent Developments/Updates
    Table 84. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 85. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 86. Pfizer Major Business
    Table 87. Pfizer Anti-tuberculosis Medicine Product and Services
    Table 88. Pfizer Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Pfizer Recent Developments/Updates
    Table 90. Pfizer Competitive Strengths & Weaknesses
    Table 91. Novartis Basic Information, Manufacturing Base and Competitors
    Table 92. Novartis Major Business
    Table 93. Novartis Anti-tuberculosis Medicine Product and Services
    Table 94. Novartis Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Novartis Recent Developments/Updates
    Table 96. Novartis Competitive Strengths & Weaknesses
    Table 97. Abbott Basic Information, Manufacturing Base and Competitors
    Table 98. Abbott Major Business
    Table 99. Abbott Anti-tuberculosis Medicine Product and Services
    Table 100. Abbott Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Abbott Recent Developments/Updates
    Table 102. Abbott Competitive Strengths & Weaknesses
    Table 103. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 104. AstraZeneca Major Business
    Table 105. AstraZeneca Anti-tuberculosis Medicine Product and Services
    Table 106. AstraZeneca Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. AstraZeneca Recent Developments/Updates
    Table 108. AstraZeneca Competitive Strengths & Weaknesses
    Table 109. Bayer Basic Information, Manufacturing Base and Competitors
    Table 110. Bayer Major Business
    Table 111. Bayer Anti-tuberculosis Medicine Product and Services
    Table 112. Bayer Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. Bayer Recent Developments/Updates
    Table 114. Bayer Competitive Strengths & Weaknesses
    Table 115. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 116. Eli Lilly Major Business
    Table 117. Eli Lilly Anti-tuberculosis Medicine Product and Services
    Table 118. Eli Lilly Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. Eli Lilly Recent Developments/Updates
    Table 120. Eli Lilly Competitive Strengths & Weaknesses
    Table 121. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 122. GlaxoSmithKline Major Business
    Table 123. GlaxoSmithKline Anti-tuberculosis Medicine Product and Services
    Table 124. GlaxoSmithKline Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. GlaxoSmithKline Recent Developments/Updates
    Table 126. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 127. Merck Basic Information, Manufacturing Base and Competitors
    Table 128. Merck Major Business
    Table 129. Merck Anti-tuberculosis Medicine Product and Services
    Table 130. Merck Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 131. Merck Recent Developments/Updates
    Table 132. Merck Competitive Strengths & Weaknesses
    Table 133. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 134. Sanofi Major Business
    Table 135. Sanofi Anti-tuberculosis Medicine Product and Services
    Table 136. Sanofi Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 137. Sanofi Recent Developments/Updates
    Table 138. Sanofi Competitive Strengths & Weaknesses
    Table 139. Chongqing Huapont Pharm Basic Information, Manufacturing Base and Competitors
    Table 140. Chongqing Huapont Pharm Major Business
    Table 141. Chongqing Huapont Pharm Anti-tuberculosis Medicine Product and Services
    Table 142. Chongqing Huapont Pharm Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 143. Chongqing Huapont Pharm Recent Developments/Updates
    Table 144. Chongqing Huapont Pharm Competitive Strengths & Weaknesses
    Table 145. Shuangding Pharm Basic Information, Manufacturing Base and Competitors
    Table 146. Shuangding Pharm Major Business
    Table 147. Shuangding Pharm Anti-tuberculosis Medicine Product and Services
    Table 148. Shuangding Pharm Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 149. Shuangding Pharm Recent Developments/Updates
    Table 150. Hongqi pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 151. Hongqi pharmaceutical Major Business
    Table 152. Hongqi pharmaceutical Anti-tuberculosis Medicine Product and Services
    Table 153. Hongqi pharmaceutical Anti-tuberculosis Medicine Production (Kiliton), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 154. Global Key Players of Anti-tuberculosis Medicine Upstream (Raw Materials)
    Table 155. Anti-tuberculosis Medicine Typical Customers
    Table 156. Anti-tuberculosis Medicine Typical Distributors
List of Figure
    Figure 1. Anti-tuberculosis Medicine Picture
    Figure 2. World Anti-tuberculosis Medicine Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Anti-tuberculosis Medicine Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Anti-tuberculosis Medicine Production (2019-2030) & (Kiliton)
    Figure 5. World Anti-tuberculosis Medicine Average Price (2019-2030) & (US$/Ton)
    Figure 6. World Anti-tuberculosis Medicine Production Value Market Share by Region (2019-2030)
    Figure 7. World Anti-tuberculosis Medicine Production Market Share by Region (2019-2030)
    Figure 8. North America Anti-tuberculosis Medicine Production (2019-2030) & (Kiliton)
    Figure 9. Europe Anti-tuberculosis Medicine Production (2019-2030) & (Kiliton)
    Figure 10. China Anti-tuberculosis Medicine Production (2019-2030) & (Kiliton)
    Figure 11. Japan Anti-tuberculosis Medicine Production (2019-2030) & (Kiliton)
    Figure 12. Anti-tuberculosis Medicine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Anti-tuberculosis Medicine Consumption (2019-2030) & (Kiliton)
    Figure 15. World Anti-tuberculosis Medicine Consumption Market Share by Region (2019-2030)
    Figure 16. United States Anti-tuberculosis Medicine Consumption (2019-2030) & (Kiliton)
    Figure 17. China Anti-tuberculosis Medicine Consumption (2019-2030) & (Kiliton)
    Figure 18. Europe Anti-tuberculosis Medicine Consumption (2019-2030) & (Kiliton)
    Figure 19. Japan Anti-tuberculosis Medicine Consumption (2019-2030) & (Kiliton)
    Figure 20. South Korea Anti-tuberculosis Medicine Consumption (2019-2030) & (Kiliton)
    Figure 21. ASEAN Anti-tuberculosis Medicine Consumption (2019-2030) & (Kiliton)
    Figure 22. India Anti-tuberculosis Medicine Consumption (2019-2030) & (Kiliton)
    Figure 23. Producer Shipments of Anti-tuberculosis Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Anti-tuberculosis Medicine Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Anti-tuberculosis Medicine Markets in 2023
    Figure 26. United States VS China: Anti-tuberculosis Medicine Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Anti-tuberculosis Medicine Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Anti-tuberculosis Medicine Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Anti-tuberculosis Medicine Production Market Share 2023
    Figure 30. China Based Manufacturers Anti-tuberculosis Medicine Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Anti-tuberculosis Medicine Production Market Share 2023
    Figure 32. World Anti-tuberculosis Medicine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Anti-tuberculosis Medicine Production Value Market Share by Type in 2023
    Figure 34. Isoniazid
    Figure 35. Rifampin
    Figure 36. Ethambutol
    Figure 37. Pyrazinamide
    Figure 38. Otherr
    Figure 39. World Anti-tuberculosis Medicine Production Market Share by Type (2019-2030)
    Figure 40. World Anti-tuberculosis Medicine Production Value Market Share by Type (2019-2030)
    Figure 41. World Anti-tuberculosis Medicine Average Price by Type (2019-2030) & (US$/Ton)
    Figure 42. World Anti-tuberculosis Medicine Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 43. World Anti-tuberculosis Medicine Production Value Market Share by Application in 2023
    Figure 44. Hospitals and Clinics
    Figure 45. Government Agencies
    Figure 46. Non-Profit Organizations
    Figure 47. Others
    Figure 48. World Anti-tuberculosis Medicine Production Market Share by Application (2019-2030)
    Figure 49. World Anti-tuberculosis Medicine Production Value Market Share by Application (2019-2030)
    Figure 50. World Anti-tuberculosis Medicine Average Price by Application (2019-2030) & (US$/Ton)
    Figure 51. Anti-tuberculosis Medicine Industry Chain
    Figure 52. Anti-tuberculosis Medicine Procurement Model
    Figure 53. Anti-tuberculosis Medicine Sales Model
    Figure 54. Anti-tuberculosis Medicine Sales Channels, Direct Sales, and Distribution
    Figure 55. Methodology
    Figure 56. Research Process and Data Source

Companies Mentioned

Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi
Chongqing Huapont Pharm
Shuangding Pharm
Hongqi pharmaceutical